DNA

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that COMET-HF (Confirmation of…

18 hours ago

DELFI Diagnostics Names Dr. Amoolya Singh as Chief Technology Officer

Strategic appointment strengthens the company's technology leadership as it seeks to revolutionize cancer diagnostics BALTIMORE and PALO ALTO, Calif., Dec.…

2 days ago

Konica Minolta and Fovia Announce Partnership

Artificial Intelligence Collaboration Showcased at RSNA 2024 CHICAGO, Dec. 2, 2024 /PRNewswire/ -- Fovia, Inc., a world leader in advanced…

2 days ago

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise statedVANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics…

4 days ago

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset

Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset Research presented at…

5 days ago

Rakovina Therapeutics Announces Private Placement Offering

The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…

6 days ago

ChemAI: AI-Driven Digital Chemistry Pioneer announces Strategic Rebrand and Key Board Appointments

LEEDS, England, Nov. 27, 2024 /PRNewswire/ -- Deepmatter, a leading innovator in digital chemistry, today unveils its rebrand to ChemAI, as part…

7 days ago

Prenetics Announces Third Quarter 2024 Financial Results

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand…

7 days ago